Navigation Links
Chemoembolization Improving as Liver Cancer Treatment
Date:1/19/2009

these microspheres absorb the chemotherapeutic agent, and then the drug is released directly into the tumor.

A month after treatment, tumors in 27 of the patients (51 percent) showed a complete response, 18 (34 percent) showed a partial response and eight (15 percent) showed stable disease. Six months later 19 of 34 patients (55.9 percent) had complete tumor response, eight (23.5 percent) had a partial response and seven (20.5 percent) had growing disease. Of the remaining 19 patients, three died, four were lost at follow-up and 12 receive other treatments.

"Patients who still had good liver function and who had tumors in only one lobe of the liver did better with this treatment," said Maurizio Grosso, M.D., chairman of the Department of Radiology at Santa Croce & Carle Hospital, Cuneo, Italy. "We're hopeful that treatment with HepaSphere will be an improvement over traditional chemoembolization."

Embolization without Chemotherapy

Researchers at the European Institute of Oncology in Milan, Italy, are studying using embolization without the chemotherapy for liver cancer. The study included 25 patients with 34 primary liver tumors. All patients received Embozene(TM) microspheres alone, without the addition of any chemotherapeutic agents in the beads. The patients had 35 sessions with the microspheres. After one month follow-up, 18 tumors (52 percent) had shrunk in size while 16 (48 percent) were the same size with no tumor growth detected. In a group of 16 tumors with a follow up ranging between six and 12 months, two tumors (12 percent) completely disappeared, seven tumors (44 percent) continued to shrink, two (12 percent) were stable and five (31 percent) grew, although they were still of a size suitable for new local treatments. To date, 14 patients have had more than one year of follow-up care and 93 percent of them are still alive.

"One concern with embolization is th
'/>"/>

SOURCE International Symposium on Endovascular Therapy
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Stroke Study Reveals a Key Target For Improving Treatment
2. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
3. Reproductive Partners Participates in New IVF Progesterone Delivery System Study
4. Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer
5. Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function
6. ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers
7. Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008
8. GSK Believes There Is No Liver Safety Issue With AVANDIA; Responds to Public Citizen Petition
9. Jennerex Completes the Treatment of First Patient Cohort in Phase 1 Trial With Intravenous Delivery of JX-594 Oncolytic Virus
10. Experts Assert That Varian Technologies Deliver Speed and Clinical Accuracy in Treating Cancer Patients
11. CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... 2014  Mark Farrah Associates (MFA), www.markfarrah.com ... of the 2015 marketplace exchange projections and insights ... According to a recent ASPE (Office of ... of Health and Human Services) report, an estimated ... plans through the Marketplace as of October 2014 ...
(Date:12/22/2014)... , Dec. 22, 2014  Pfenex Inc. (NYSE MKT: ... anthrax vaccine, has been filed and is now open ... by the Department of Health and Human Services (HHS), ... "We are extremely pleased to have the ... This represents a significant milestone in our company,s partnership ...
(Date:12/22/2014)... 2014 TWi Biotechnology, Inc., today announced ... AC-201, TWi Biotechnology,s lead drug candidate, from The ... for patent application numbered 201180018154.8.  This ... active metabolite for treatment of type II diabetes.  ... using AC-201 for type II diabetes, and provides ...
Breaking Medicine Technology:Insights into the Marketplace and Individual Market Growth 2Pfenex Announces Active IND and Additional BARDA Funding for Recombinant Anthrax Vaccine Program, Px563L 2Pfenex Announces Active IND and Additional BARDA Funding for Recombinant Anthrax Vaccine Program, Px563L 3TWi Biotechnology Receives Notice of Patent Allowance for Its Lead Drug Candidate AC-201 for the Indication of Type II Diabetes in China 2TWi Biotechnology Receives Notice of Patent Allowance for Its Lead Drug Candidate AC-201 for the Indication of Type II Diabetes in China 3
... 15 This year,s American Friends of Rabin Medical ... to be an unforgettable evening. With Larry King ... being held on the historic Intrepid Sea, Air & Space ... be in attendance, including diplomats, civic, business, medical and philanthropic ...
... , EAST BRUNSWICK, N.J., Oct. 15 Savient Pharmaceuticals, ... of its previously announced underwritten public offering. Prior to ... purchase an additional 645,000 shares of common stock. As ... of its common stock at a price to the ...
Cached Medicine Technology:Larry King to Host 10th Annual American Friends of Rabin Medical Center 'Broadway on the Hudson' Gala 2Larry King to Host 10th Annual American Friends of Rabin Medical Center 'Broadway on the Hudson' Gala 3Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option 2
(Date:12/22/2014)... (PRWEB) December 22, 2014 Fad diets ... changed. The reason why most fad diets have hung ... The problem with fad diets is that, as the body ... the dieter uncertain of how to reset the metabolism to ... reason, Diet Doc developed their all-inclusive diet plans ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 The founders ... BLS and ACLS online certification provider, are proud to ... . The updated site now features a more user-friendly ... ever to use. , As a company spokesperson ... is now consolidated into a single page during the ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 ... current Ebola virus epidemic are receiving further ... government agencies, nongovernmental organizations (NGOs) and other ... ongoing, healthcare workers, emergency responders, patients and ... such as the CmTP MediDefense system ...
(Date:12/22/2014)... Physicians in China are most eagerly ... of non-Hodgkin’s lymphoma (NHL), according to a new report ... consulting firm. MabThera is the only biologic available to ... form of NHL. , According to Kantar Health’s report, ... of NHL in China has been growing and is ...
(Date:12/22/2014)... OH (PRWEB) December 22, 2014 Explorys, ... three additions to its leadership team: Greg Yarrington as ... of Engineering, and Patrick Wells as Vice President of ... to add 80 new jobs in 2015 to support ... expansion of its platform-as-a-service offerings, and growth of its ...
Breaking Medicine News(10 mins):Health News:Diet Doc Announces the Difference Between Fad Diets and Real Weight Loss Programs to Help Dieters Make the Best Choice 2Health News:Diet Doc Announces the Difference Between Fad Diets and Real Weight Loss Programs to Help Dieters Make the Best Choice 3Health News:Diet Doc Announces the Difference Between Fad Diets and Real Weight Loss Programs to Help Dieters Make the Best Choice 4Health News:ACLS Online Certification Website ACLS-PALS-BLS.com Now Features a New and User-Friendly Layout 2Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 2Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 3Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 4Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 5Health News:Physicians in China See Most Significant Demand for MabThera Biosimilar 2Health News:Physicians in China See Most Significant Demand for MabThera Biosimilar 3Health News:Explorys Continues to Experience Rapid Growth, Adds Three Healthcare IT Executives to Its Leadership Team 2Health News:Explorys Continues to Experience Rapid Growth, Adds Three Healthcare IT Executives to Its Leadership Team 3
... at Wake Forest University Baptist Medical Center (WFUBMC) have discovered ... breast cancer. For the first time, a peptide found in ... of human breast tumors in mice, according to a study ... Patricia E. Gallagher, Ph.D., and E. Ann Tallant, Ph.D., scientists ...
... Hydrocephalus in Ugandan children and other developing countries is ... by previous bacterial infection, according to an international team ... believe that the best approach to this problem is ... grand medical mystery," said Steven Schiff, the Brush Chair ...
... , THURSDAY, Dec. 30 (HealthDay News) -- Certain ... a new study finds. Because of increasing urbanization, ... more than ever before. For example, foxes, raccoons and ... mice, rats, birds and other prey. For this ...
... , , , , , ... , AUDIO: Its not news ... Click here for more information. , ... , , , , , ...
... -- Researchers report that they,ve gained insight into the workings ... in how the body stores fat to protect against future ... be linked to both insulin sensitivity and the survival of ... all these different phenomena," Dr. Philipp Scherer, a professor of ...
... Reporter , THURSDAY, Dec. 29 (HealthDay News) -- As fears ... gripped much of the United States the past two winters, George ... As vice president of human resources for a Fort Lauderdale commercial ... and protect not only the company,s employees but also the tenants ...
Cached Medicine News:Health News:Peptide delivers 1-2 punch to breast cancer in pre-clinical study 2Health News:Infant hydrocephalus, seasonal and linked to farm animals in Uganda 2Health News:Infant hydrocephalus, seasonal and linked to farm animals in Uganda 3Health News:Infant hydrocephalus, seasonal and linked to farm animals in Uganda 4Health News:Consistent exercise associated with lower risk of colon cancer death 2Health News:Consistent exercise associated with lower risk of colon cancer death 3Health News:Research Sheds Light on 'Starvation Hormone' 2Health News:How One Company Fought the Flu 2
... a large body for increased stability ... centimeters center-to-center) to resist the wear ... indicators are molded into the body. ... bar electrode styles. Shielded bar electrodes ...
... Cadwell's custom bars have a ... solid, machined contacts (spaced 3 centimeters ... tear of repeated cleaning. Polarity indicators ... convenient, snap-on handle fits our bar ...
The Surgifresh mini has the same rugged construction as the Plume-inator. It is the ideal size for operating room, clinic and office settings. This unit includes a filter test button, hospital grade ...
... Evolutionary refractive lens technology for ... safety and efficacy, demonstrates quality of ... contact lens correction. The lens is ... and is now available for the ...
Medicine Products: